Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022.

Curr Cardiol Rep · 2022 · PMC9130990 · PMID 35612721

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Recurrent pericarditis occurred in 90% of patients assigned to placebo and in 18% of those assigned to anakinra, a highly significant difference.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.